Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App

Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...

New group of potential diabetes drugs with fewer side effects can reprogram insulin-resistant cells to be healthier

Using a blend of computer modeling, structural and cell-based studies, scientists at The Wertheim UF Scripps Institute have ...

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook

Phase 2 BESTOW trial data evaluating tegoprubart in kidney transplantation showed favorable efficacy, safety and tolerability, supporting advancement into Phase 3 development Reported positive ...
Mirage News

HiPerGator Boosts Diabetes Drug Discovery Efforts

Using a blend of computer modeling, structural and cell-based studies, scientists at The Wertheim UF Scripps Institute have ...

Welldoc Submits 510(k) to FDA for CGM-Informed Glucose Prediction Feature

Welldoc®, a leader in AI-powered cardiometabolic health solutions, today announced the submission of a 510(k) premarket ...

Pioneering Scientist Behind Revolutionary Weight-Loss Drugs and Leading Mathematician Honored with 2026 King Faisal Prize

Professors Svetlana Mojsov and Carlos Kenig, among other eminent figures, were selected to win the 48th session of the prize.
Medical Device Network

ViCentra adds $13m in second close of Series D funding round

ViCentra has raised $13m in the second close of its Series D funding round that will be directed towards advancing ...